Malaria continues to represent a very serious health problem in the tropics
. The current methods of clinical treatment are showing deficiencies due to
the increased incidence of resistance in the parasite. In the present pape
r we report the design, synthesis, and evaluation of potential antimalarial
agents against a novel target, protein farnesyltransferase. We show that t
he most potent compounds are active against Plasmodium falciparum in vitro
at submicromolar concentrations. (C) 2001 Elsevier Science Ltd. All rights
reserved.